Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 31Gynecologic 4Gastrointestinal 4Head & Neck 3Breast 2Other solid neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Advanced Solid Tumor 104Advanced Solid Tumors 92Solid Tumor 69Mesothelioma 42Mesothelioma, Malignant 41Solid Tumors 37Carcinoma, Non-Small-Cell Lung 25Solid Tumor, Adult 22Stomach Neoplasms 15Ovarian Neoplasms 15Esophageal Neoplasms 15Melanoma 13Colorectal Neoplasms 13Carcinoma, Renal Cell 13Endometrial Neoplasms 11Unspecified Adult Solid Tumor, Protocol Specific 10Pancreatic Neoplasms 10Neoplasms 10Neoplasm Metastasis 10Advanced Malignant Solid Tumor 10Uterine Cervical Neoplasms 9Malignant Solid Tumor 9Lung Neoplasms 9Breast Neoplasms 9Triple Negative Breast Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Sarcoma 8Advanced or Metastatic Solid Tumors 8Carcinoma, Hepatocellular 7Small Cell Lung Carcinoma 6

Interventions

Pentostatin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Adenocarcinoma of Lung × Other solid neoplasm × Clear all
NCT01362790 2019-06-06

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
55 enrolled 22 charts
GastrointestinalOther solid neoplasmThoracic

Adenocarcinoma of Lung, Mesothelioma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡